Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells

Fig. 2

Phenotypic characterization of DC cells. a Representative images of adherent cultured PBMC-isolated precursor monocytes (day 0), inflammatory cytokine-stimulated maturing DC cells (day 4), and peptide-loaded mature DC cells (day 7). The peptide-sensitized DC cells exhibited the typical dendritic appearance. Magnification, × 40; bars, 200 μm. b FACS analysis. Results showed that the peptide-stimulated DC cells, isolated from two representative PBMC preparations, expressed higher levels of three DC-associated surface markers, CD80, CD83, and CD86

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512